John E. Sagartz serves as Executive at BIOANALYTICAL SYSTEMS INC, where they oversee executive responsibilities. Since joining the company, John E. Sagartz has executed 14 insider transactions totaling $195.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 10, 2024 involved receiving (via award) 20,000 shares valued at $0.
John E. Sagartz currently holds 712,047 shares of BIOANALYTICAL SYSTEMS INC (BASI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John E. Sagartz has been a net buyer of BASI stock. They have purchased $195.5K and sold $0 worth of shares.
John E. Sagartz's most recent insider trade was on Aug 10, 2024, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.91 |
| Discretionary |
| Jan 18, 2023 | NOTV | $0 | Award | 5,917 | $N/A | Discretionary |
| Feb 17, 2022 | NOTV | $50.0K | Purchase | 2,506 | $19.95 | Discretionary |
| Feb 15, 2022 | NOTV | $0 | Award | 30,000 | $N/A | Discretionary |
| Jun 7, 2021 | NOTV | $50.0K | Purchase | 1,742 | $28.70 | Discretionary |
| May 28, 2021 | NOTV | $49.9K | Purchase | 2,012 | $24.78 | Discretionary |
| May 27, 2021 | NOTV | $120 | Purchase | 5 | $24.00 | Discretionary |
| May 7, 2021 | NOTV | $0 | Award | 880 | $N/A | Discretionary |
| Dec 2, 2020 | BASI | $0 | Award | 9,653 | $N/A | Discretionary |
| Aug 19, 2020 | BASI | $17.7K | Purchase | 3,733 | $4.75 | Discretionary |
| Dec 2, 2019 | BASI | $0 | Award | 8,974 | $N/A | Discretionary |
| Mar 14, 2019 | BASI | $2.7K | Purchase | 1,400 | $1.94 | Discretionary |
| Feb 19, 2019 | BASI | $3.6K | Small Acquisition | 2,500 | $1.43 | Discretionary |